Boston Children's Hospital
Boston, MA
Accepting patients
A Phase 1 Trial of CIML NK Cell Infusion for Myeloid Disease Relapse After Hematopoietic Cell Transplantation
- Natural Killer Cells
- Chemotherapy
- Phase 1
Accepting patients
MORE
A Pilot Study to Evaluate the Feasibility of Post-Hematopoietic Stem Cell Transplant Prophylaxis With Decitabine Combined With Filgrastim for Children and Young Adults With AML, MDS and Related Myeloid Malignancies
- Hypomethylating Agents (HMA)
- White Blood Cell Stimulant
- Maintenance
- Phase 2